SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3526Bob That Q&A was interesting. As I understand it, genasense was dosed at conor00-5/6/2004
3525i agree. the second half of this year will answer a lot of questions and there ibob zagorin-5/6/2004
3524Hi CC Key points, IMO: According to Parshall (CFO), ISIS has sufficient cash toconor00-5/6/2004
3523Isis Pharmaceuticals Reports Financial Results and Highlights for the First Quarbob zagorin-5/6/2004
3522Isis Pharmaceuticals Announces Extension of Antisense Cancer Drug Discovery Collnigel bates-5/6/2004
3521from ASCO program.. this is ISIS + OncoGenex... A phase I pharmacokinetic (PK) bob zagorin-5/4/2004
3520Antisense Drug Demonstrates Potential to Treat Progressive Form of ALS Tuesday Abob zagorin-4/27/2004
3519well my advice art, fwiw, with bios like isis is to have a core position and addbob zagorin-4/27/2004
3518Why is ISIS moving up? I think if you look at its recent moves upward, they werArt Bechhoefer-4/27/2004
3517And, now we have ISIS moving. A fairly straight up move today. Why? mjMJ-4/26/2004
3516>>Looks like a winner.<< That's got to be the understatement of Art Bechhoefer-4/26/2004
3515i can only speculate... GNTA story in WSJ portends well perhaps for antisense. bob zagorin-4/26/2004
3514Anyone hear any news today? Moved up on relatively high volume.The Band Leader-4/26/2004
3513Antisense Therapeutics CEO Mark Diamond Interviewed by Wall Street Reporter VICbob zagorin-4/22/2004
3512Bob I still follow ISIS just not as actively. Saw the article also-----suggestMJ-4/22/2004
3511Hi Bob I saw this too. Safe to say that if ISIS get any kind of approval from thconor00-4/21/2004
3510MONDAY, APRIL 19, 2004 (Barron's) INVESTING IN HEALTH Ripe for the bob zagorin-4/19/2004
3509reposted fron yahoo gnta thread. any comments on isis events? "...I'm bob zagorin-4/8/2004
3508wonder if isis get license fees from this? AVI BioPharma Reports Anti-Cancer Efbob zagorin-4/1/2004
3507[ISIS 5132 and ISIS 13650 against tumors expressing Raf-1 in ovarian cancer] &gtuck-3/26/2004
3506they had a conference call with slides about 2-3 weeks ago. well worth listeningbob zagorin-3/22/2004
3505Thanks, Bob. Sounds interesting. Any estimates of how big a tiger we are talkiThomas-3/22/2004
3504investors.com/editorial/health02.asp?v=3/20 LOOKING AHEAD Analysts will pay clobob zagorin-3/22/2004
3503The three companies I follow that are involved in antisense research and developArt Bechhoefer-3/12/2004
3502Hi From the cc's, I think all drug trial results will be reported this year conor00-3/12/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News